Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Change in Receivables (2019 - 2025)

Quantum Biopharma's Change in Receivables history spans 7 years, with the latest figure at -$99701.0 for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 63.14% to -$99701.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$208562.0, a 23.5% increase, with the full-year FY2025 number at $231053.0, down 38.33% from a year prior.
  • Change in Receivables hit -$99701.0 in Q4 2025 for Quantum Biopharma, down from $78300.0 in the prior quarter.
  • Over the last five years, Change in Receivables for QNTM hit a ceiling of $951503.0 in Q2 2022 and a floor of -$270474.0 in Q4 2024.
  • Historically, Change in Receivables has averaged $203000.2 across 5 years, with a median of $137407.5 in 2022.
  • Biggest five-year swings in Change in Receivables: skyrocketed 149.13% in 2023 and later crashed 1758.42% in 2024.
  • Tracing QNTM's Change in Receivables over 5 years: stood at $101234.0 in 2021, then crashed by 149.21% to -$49813.0 in 2022, then surged by 70.78% to -$14554.0 in 2023, then crashed by 1758.42% to -$270474.0 in 2024, then surged by 63.14% to -$99701.0 in 2025.
  • Business Quant data shows Change in Receivables for QNTM at -$99701.0 in Q4 2025, $78300.0 in Q3 2025, and $193198.0 in Q2 2025.